CDX-2, MUC-2 and B-catenin as intestinal markers in pure mucinous carcinoma of the breast

Biol Res. 2014 Sep 18;47(1):43. doi: 10.1186/0717-6287-47-43.

Abstract

Background: Pure mucinous adenocarcinoma of the breast is a rare entity characterized by the production of variable amounts of mucin comprising 1% to 6% of breast carcinomas. Some mucinous adenocarcinomas have shown expression of intestinal differentiation markers such as MUC-2. This study examines the expression of intestinal differentiation markers in this type of breast carcinoma.

Results: Twenty-two cases of pure mucinous adenocarcinoma of the breast were assessed. Immunochemistry was performed for beta-catenin, CDX-2 and MUC-2. All cases were positive for B-catenin. MUC-2 positivity was observed in all cases; 63. 6% were 3 plus positive. All cases were negative for CDX-2.

Conclusions: These results suggest that mucinous breast carcinomas express some markers of intestinal differentiation, such as MUC-2 and beta-catenin; however, future studies with a larger series of cases and using molecular techniques that help affirm these results are needed.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Adenocarcinoma, Mucinous / chemistry*
  • Adenocarcinoma, Mucinous / pathology
  • Adult
  • Aged
  • Aged, 80 and over
  • Antigens, Differentiation / analysis
  • Biomarkers, Tumor / analysis*
  • Breast Neoplasms / chemistry*
  • Breast Neoplasms / pathology
  • CDX2 Transcription Factor
  • Female
  • Homeodomain Proteins / analysis*
  • Humans
  • Immunohistochemistry
  • Intestinal Mucosa / chemistry*
  • Middle Aged
  • Mucin-2 / analysis*
  • Retrospective Studies
  • Trans-Activators / analysis*
  • beta Catenin / analysis*

Substances

  • Antigens, Differentiation
  • Biomarkers, Tumor
  • CDX2 Transcription Factor
  • Homeodomain Proteins
  • MUC2 protein, human
  • Mucin-2
  • Trans-Activators
  • beta Catenin